Table 3.
Comparison of serum potassium values between the kanamycin-based group and the capreomycin-based group at the initial visit, first month, and second month of treatment.
| N | Potassium | p value | |||
|---|---|---|---|---|---|
| Mean ± SD (mEq/L) | Min-max (mEq/L) | ||||
| Initial visit | Kanamycin | 44 | 4.0 ± 0.4 | 3.3–4.8 | 0.100 |
| Capreomycin | 40 | 4.1 ± 0.5 | 3.5–5.5 | ||
|
| |||||
| First month | Kanamycin | 44 | 3.6 ± 0.4 | 2.8–4.3 | 0.086 |
| Capreomycin | 40 | 3.4 ± 0.7 | 1.8–4.7 | ||
|
| |||||
| Second month | Kanamycin | 44 | 3.7 ± 0.5 | 2.4–4.7 | <0.001 |
| Capreomycin | 40 | 3.2 ± 0.6 | 1.8–4.2 | ||
SD, standard deviation; min, minimum value; max, maximum value; analyzed using the unpaired t-test.